HUP0100742A3 - Use of cycloprop[14,15]-estratriol derivatives for producing pharmaceutical preparations for supplementing oestrogen deficiency in the central nervous system - Google Patents

Use of cycloprop[14,15]-estratriol derivatives for producing pharmaceutical preparations for supplementing oestrogen deficiency in the central nervous system

Info

Publication number
HUP0100742A3
HUP0100742A3 HU0100742A HUP0100742A HUP0100742A3 HU P0100742 A3 HUP0100742 A3 HU P0100742A3 HU 0100742 A HU0100742 A HU 0100742A HU P0100742 A HUP0100742 A HU P0100742A HU P0100742 A3 HUP0100742 A3 HU P0100742A3
Authority
HU
Hungary
Prior art keywords
estratriol
cycloprop
supplementing
derivatives
nervous system
Prior art date
Application number
HU0100742A
Other languages
English (en)
Original Assignee
Jenapharm Gmbh Und Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998121831 external-priority patent/DE19821831A1/de
Application filed by Jenapharm Gmbh Und Co Kg filed Critical Jenapharm Gmbh Und Co Kg
Publication of HUP0100742A2 publication Critical patent/HUP0100742A2/hu
Publication of HUP0100742A3 publication Critical patent/HUP0100742A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0100742A 1998-02-20 1999-02-10 Use of cycloprop[14,15]-estratriol derivatives for producing pharmaceutical preparations for supplementing oestrogen deficiency in the central nervous system HUP0100742A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19807264 1998-02-20
DE1998121831 DE19821831A1 (de) 1998-05-15 1998-05-15 Pharmazeutische Präparate zur gezielten Substitution des Estrogenmangels im Zentralnervensystem
PCT/DE1999/000353 WO1999042108A1 (de) 1998-02-20 1999-02-10 Pharmazeutische präparate zur gezielten substitution des estrogenmangels im zentralnervensystem

Publications (2)

Publication Number Publication Date
HUP0100742A2 HUP0100742A2 (hu) 2001-09-28
HUP0100742A3 true HUP0100742A3 (en) 2002-07-29

Family

ID=26044035

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100742A HUP0100742A3 (en) 1998-02-20 1999-02-10 Use of cycloprop[14,15]-estratriol derivatives for producing pharmaceutical preparations for supplementing oestrogen deficiency in the central nervous system

Country Status (24)

Country Link
EP (1) EP1056460B1 (hu)
JP (1) JP2002503694A (hu)
KR (1) KR20010041107A (hu)
CN (1) CN1291102A (hu)
AT (1) ATE252388T1 (hu)
AU (1) AU739071C (hu)
BG (1) BG104689A (hu)
BR (1) BR9909205A (hu)
CA (1) CA2321498A1 (hu)
CZ (1) CZ291764B6 (hu)
DE (1) DE59907446D1 (hu)
EA (1) EA002707B1 (hu)
EE (1) EE03906B1 (hu)
HU (1) HUP0100742A3 (hu)
ID (1) ID27069A (hu)
IL (1) IL137727A0 (hu)
IS (1) IS5571A (hu)
NO (1) NO20004153L (hu)
NZ (1) NZ506049A (hu)
PL (1) PL342313A1 (hu)
SK (1) SK12152000A3 (hu)
TR (1) TR200002400T2 (hu)
UA (1) UA57830C2 (hu)
WO (1) WO1999042108A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2253318T3 (es) * 2001-11-07 2006-06-01 Schering Ag Cribado in vitro de ligandos del receptor de estrogeno.
CN112189624A (zh) * 2020-09-08 2021-01-08 山东第一医科大学(山东省医学科学院) 一种利用受体基因沉默技术构建和鉴定女性ad模型的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897389A (en) * 1984-10-29 1990-01-30 Chaovanee Aroonsakul Treating central nervous system diseases
US4791099A (en) * 1984-10-29 1988-12-13 Chaovanee Aroonsakul Method of treatment for central nervous system diseases such as Alzheimer's's disease
DE4239946C2 (de) * 1992-11-27 2001-09-13 Jenapharm Gmbh Estranderivate mit einer 14alpha,15alpha-Methylengruppe und Verfahren zu ihrer Herstellung
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4338314C1 (de) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE19524937A1 (de) * 1995-07-08 1997-01-09 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen und zur medikamentösen Substitution beim Mann
WO1997003661A1 (en) * 1995-07-24 1997-02-06 University Of Florida Research Foundation, Incorporated Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells

Also Published As

Publication number Publication date
PL342313A1 (en) 2001-06-04
EP1056460B1 (de) 2003-10-22
CN1291102A (zh) 2001-04-11
EE200000477A (et) 2001-12-17
KR20010041107A (ko) 2001-05-15
AU2920999A (en) 1999-09-06
NZ506049A (en) 2002-09-27
CZ291764B6 (cs) 2003-05-14
JP2002503694A (ja) 2002-02-05
DE59907446D1 (de) 2003-11-27
BG104689A (en) 2001-04-30
EA002707B1 (ru) 2002-08-29
CZ20002938A3 (cs) 2001-01-17
WO1999042108A1 (de) 1999-08-26
TR200002400T2 (tr) 2000-11-21
EP1056460A1 (de) 2000-12-06
CA2321498A1 (en) 1999-08-26
ATE252388T1 (de) 2003-11-15
NO20004153L (no) 2000-10-09
UA57830C2 (uk) 2003-07-15
IL137727A0 (en) 2001-10-31
ID27069A (id) 2001-02-22
EA200000858A1 (ru) 2001-04-23
IS5571A (is) 2000-07-24
SK12152000A3 (sk) 2001-02-12
BR9909205A (pt) 2000-11-14
EE03906B1 (et) 2002-12-16
NO20004153D0 (no) 2000-08-18
HUP0100742A2 (hu) 2001-09-28
AU739071C (en) 2002-04-11
AU739071B2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
IL147923A0 (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
IL147925A0 (en) 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
HU9802224D0 (en) Pyrazol derivatives, process for producing them and their use as medicament
HUP0003073A3 (en) Benzenesulfonamide derivatives, process for producing them and their use as medicines
HU9802422D0 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and their medical use
PL347506A1 (en) 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
HU9602305D0 (en) 4-heterocyclyl-substituted quinazoline derivatives, process for their preparation and their use as anti-cancer agents
HUP9800138A3 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
HU9802653D0 (en) Substituted imidazolidine derivatives, process for producing them, their use, and pharmaceutical compositions containing them
HRP20010115B1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
AU8627898A (en) Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
HUP9701270A3 (en) Neuraminic acid derivatives, medicaments containing them and their use for producing medicaments
HUP0002300A3 (en) Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
HK1010885A1 (en) 10,13,15-trioxatricyclo [9.2.1.1.9.6]-pentadecanone-derivatives, process for their preparation and pharmaceutical containing them
HUP0100742A3 (en) Use of cycloprop[14,15]-estratriol derivatives for producing pharmaceutical preparations for supplementing oestrogen deficiency in the central nervous system
HK1015763A1 (en) Benzoxazindione derivatives, process for their preparation and their use
HU9900263D0 (en) 11-acetyl-12,13-dioxabicyclo[8.2.1.]tridecenon derivatives, process for producing them and pharmaceutical compositions containing them
HUP9701284A3 (en) Use of 2,3-benzodiazepine derivatives for producing pharmaceutical compositions for treating and prophylacting illnesses and conditions connected with the endogene opioide system
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
HUP0100584A3 (en) Triazepinones, process for their preparation and their therapeutic application